SGPHealthcare
SpyGlass Pharma, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for SpyGlass Pharma, Inc. (SGP), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are SGP insiders buying or selling?
In the last 12 months, SpyGlass Pharma, Inc. insiders reported 15 open-market purchases ($221.5M) and 0 sales ($0) — net buying of $221.5M. Since February 2026, Trabud has recorded 15 Form 4 filings for SGP: 15 buys ($221.5M) and 0 sells ($0).
Source: SEC EDGAR Form 4
Key Statistics (February 2026 – Feb 11, 2026)
Total Form 4 filings
15
SEC EDGAR
Insider filers
15
Insider buys (15)
$221.5M
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $221.5M in net buying since February 2026, and $221.5M in net buying over the last 12 months.
Recent SGP insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Peter Kolchinsky | Director, 10% Owner | Purchase | 3.7M | $16.00 | $59.0M | SEC ↗ |
| Feb 11, 2026 | Ali Behbahani | Director, 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Anthony A. Florence Jr. | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Forest Baskett | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | New Enterprise Associates 17, L.P. | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Rick Yang | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Mohamad Makhzoumi | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Scott D Sandell | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Carmen Chang | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Paul Edward Walker | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Edward T Mathers | 10% Owner | Purchase | 937.5K | $16.00 | $15.0M | SEC ↗ |
| Feb 11, 2026 | Geoffrey B Pardo | Director | Purchase | 312.5K | $16.00 | $5.0M | SEC ↗ |
| Feb 11, 2026 | Bilal Arshad Khan | Director | Purchase | 135.0K | $16.00 | $2.2M | SEC ↗ |
| Feb 10, 2026 | Kirk G. Nielsen | Director | Purchase | 165.0K | $16.00 | $2.6M | SEC ↗ |
| Feb 10, 2026 | Kirk G. Nielsen | 10% Owner | Purchase | 165.0K | $16.00 | $2.6M | SEC ↗ |
Showing the 15 most recent of 15 Form 4 filings for SpyGlass Pharma, Inc..
Most active SGP insiders
- Ali Behbahani1 filing
- Anthony A. Florence Jr.1 filing
- Bilal Arshad Khan1 filing
- Carmen Chang1 filing
- Edward T Mathers1 filing
Ask anything about SGP insider activity
Use Trabud's AI agent to query SpyGlass Pharma, Inc.'s Form 4 history in plain English — "Show me SGP CEO purchases this year" or compare it against any other ticker.
Open the AI agentSGP insider trading FAQ
Are SpyGlass Pharma, Inc. insiders buying or selling?
In the last 12 months, SpyGlass Pharma, Inc. insiders reported 15 open-market purchases ($221.5M) and 0 sales ($0) — net buying of $221.5M. Since February 2026, Trabud has recorded 15 Form 4 filings for SGP: 15 buys ($221.5M) and 0 sells ($0). Over the full record that is net buying of $221.5M.
How many insiders trade SGP stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for SpyGlass Pharma, Inc.. The most recent filing was accepted on Feb 11, 2026.
Where does Trabud get SGP insider trading data?
All SGP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.